nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—hypertension—focal segmental glomerulosclerosis	0.437	1	CtDrD
Telmisartan—AGTR1—focal segmental glomerulosclerosis	0.33	1	CbGaD
Telmisartan—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0602	0.38	CbGbCtD
Telmisartan—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0544	0.343	CbGbCtD
Telmisartan—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0243	0.153	CbGbCtD
Telmisartan—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0196	0.124	CbGbCtD
Telmisartan—AGTR1—nephron—focal segmental glomerulosclerosis	0.0051	0.243	CbGeAlD
Telmisartan—PPARG—nephron—focal segmental glomerulosclerosis	0.0042	0.2	CbGeAlD
Telmisartan—Unspecified disorder of autonomic nervous system—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.06	CcSEcCtD
Telmisartan—AGTR1—endothelium—focal segmental glomerulosclerosis	0.00241	0.114	CbGeAlD
Telmisartan—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.0507	CcSEcCtD
Telmisartan—PPARG—endothelium—focal segmental glomerulosclerosis	0.00198	0.094	CbGeAlD
Telmisartan—Azilsartan medoxomil—AGTR1—focal segmental glomerulosclerosis	0.00149	0.439	CrCbGaD
Telmisartan—AGTR1—nephron tubule—focal segmental glomerulosclerosis	0.0011	0.0524	CbGeAlD
Telmisartan—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.000978	0.0238	CcSEcCtD
Telmisartan—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.000978	0.0238	CcSEcCtD
Telmisartan—AGTR1—kidney—focal segmental glomerulosclerosis	0.000968	0.046	CbGeAlD
Telmisartan—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.000964	0.0234	CcSEcCtD
Telmisartan—AGTR1—cortex of kidney—focal segmental glomerulosclerosis	0.000943	0.0448	CbGeAlD
Telmisartan—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000797	0.0379	CbGeAlD
Telmisartan—PPARG—kidney—focal segmental glomerulosclerosis	0.000796	0.0379	CbGeAlD
Telmisartan—Olmesartan—AGTR1—focal segmental glomerulosclerosis	0.00071	0.209	CrCbGaD
Telmisartan—ABCC2—kidney—focal segmental glomerulosclerosis	0.0007	0.0333	CbGeAlD
Telmisartan—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000682	0.0324	CbGeAlD
Telmisartan—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.0162	CcSEcCtD
Telmisartan—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.0161	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00066	0.0744	CbGpPWpGaD
Telmisartan—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.0149	CcSEcCtD
Telmisartan—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.0148	CcSEcCtD
Telmisartan—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.0145	CcSEcCtD
Telmisartan—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000581	0.0276	CbGeAlD
Telmisartan—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.0141	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.000563	0.0635	CbGpPWpGaD
Telmisartan—Candesartan—AGTR1—focal segmental glomerulosclerosis	0.000552	0.162	CrCbGaD
Telmisartan—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0131	CcSEcCtD
Telmisartan—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.013	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.000528	0.0595	CbGpPWpGaD
Telmisartan—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0126	CcSEcCtD
Telmisartan—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.0124	CcSEcCtD
Telmisartan—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.0123	CcSEcCtD
Telmisartan—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.0117	CcSEcCtD
Telmisartan—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.000473	0.0115	CcSEcCtD
Telmisartan—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.0113	CcSEcCtD
Telmisartan—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000459	0.0112	CcSEcCtD
Telmisartan—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.0106	CcSEcCtD
Telmisartan—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.01	CcSEcCtD
Telmisartan—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.00998	CcSEcCtD
Telmisartan—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000394	0.0096	CcSEcCtD
Telmisartan—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00955	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.000391	0.044	CbGpPWpGaD
Telmisartan—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.00942	CcSEcCtD
Telmisartan—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000383	0.00933	CcSEcCtD
Telmisartan—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000382	0.00929	CcSEcCtD
Telmisartan—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00889	CcSEcCtD
Telmisartan—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00881	CcSEcCtD
Telmisartan—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00877	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000357	0.0402	CbGpPWpGaD
Telmisartan—Losartan—AGTR1—focal segmental glomerulosclerosis	0.000356	0.105	CrCbGaD
Telmisartan—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000356	0.00866	CcSEcCtD
Telmisartan—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000353	0.00859	CcSEcCtD
Telmisartan—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00855	CcSEcCtD
Telmisartan—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000343	0.00835	CcSEcCtD
Telmisartan—SLCO1B3—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000339	0.0382	CbGpPWpGaD
Telmisartan—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.00822	CcSEcCtD
Telmisartan—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00782	CcSEcCtD
Telmisartan—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00765	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.000311	0.0351	CbGpPWpGaD
Telmisartan—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00754	CcSEcCtD
Telmisartan—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.00752	CcSEcCtD
Telmisartan—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000304	0.00739	CcSEcCtD
Telmisartan—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.00736	CcSEcCtD
Telmisartan—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000298	0.00726	CcSEcCtD
Telmisartan—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.0071	CcSEcCtD
Telmisartan—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.00703	CcSEcCtD
Telmisartan—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000286	0.0136	CbGeAlD
Telmisartan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00694	CcSEcCtD
Telmisartan—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000284	0.00692	CcSEcCtD
Telmisartan—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00675	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00671	CcSEcCtD
Telmisartan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.00667	CcSEcCtD
Telmisartan—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000266	0.00647	CcSEcCtD
Telmisartan—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00643	CcSEcCtD
Telmisartan—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00643	CcSEcCtD
Telmisartan—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00641	CcSEcCtD
Telmisartan—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000261	0.00634	CcSEcCtD
Telmisartan—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00632	CcSEcCtD
Telmisartan—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000259	0.00631	CcSEcCtD
Telmisartan—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000259	0.00631	CcSEcCtD
Telmisartan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.00625	CcSEcCtD
Telmisartan—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.00625	CcSEcCtD
Telmisartan—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00613	CcSEcCtD
Telmisartan—ABCB1—kidney—focal segmental glomerulosclerosis	0.000252	0.012	CbGeAlD
Telmisartan—SLCO1B3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000251	0.0283	CbGpPWpGaD
Telmisartan—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.00608	CcSEcCtD
Telmisartan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000249	0.00607	CcSEcCtD
Telmisartan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.00604	CcSEcCtD
Telmisartan—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000245	0.0117	CbGeAlD
Telmisartan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00579	CcSEcCtD
Telmisartan—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00575	CcSEcCtD
Telmisartan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00573	CcSEcCtD
Telmisartan—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.0057	CcSEcCtD
Telmisartan—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000233	0.00568	CcSEcCtD
Telmisartan—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000233	0.00566	CcSEcCtD
Telmisartan—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.00557	CcSEcCtD
Telmisartan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00538	CcSEcCtD
Telmisartan—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.00536	CcSEcCtD
Telmisartan—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00524	CcSEcCtD
Telmisartan—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.0052	CcSEcCtD
Telmisartan—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000213	0.00518	CcSEcCtD
Telmisartan—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00516	CcSEcCtD
Telmisartan—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000208	0.00506	CcSEcCtD
Telmisartan—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00503	CcSEcCtD
Telmisartan—Losartan—ACE—focal segmental glomerulosclerosis	0.000206	0.0605	CrCbGaD
Telmisartan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00495	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.000203	0.0229	CbGpPWpGaD
Telmisartan—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000203	0.00493	CcSEcCtD
Telmisartan—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00492	CcSEcCtD
Telmisartan—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00488	CcSEcCtD
Telmisartan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00483	CcSEcCtD
Telmisartan—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00466	CcSEcCtD
Telmisartan—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00465	CcSEcCtD
Telmisartan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00459	CcSEcCtD
Telmisartan—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00453	CcSEcCtD
Telmisartan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00452	CcSEcCtD
Telmisartan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00439	CcSEcCtD
Telmisartan—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00434	CcSEcCtD
Telmisartan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00428	CcSEcCtD
Telmisartan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00428	CcSEcCtD
Telmisartan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00428	CcSEcCtD
Telmisartan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00427	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00425	CcSEcCtD
Telmisartan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00423	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000173	0.0195	CbGpPWpGaD
Telmisartan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000172	0.00419	CcSEcCtD
Telmisartan—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.0041	CcSEcCtD
Telmisartan—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.0041	CcSEcCtD
Telmisartan—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00408	CcSEcCtD
Telmisartan—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00402	CcSEcCtD
Telmisartan—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00402	CcSEcCtD
Telmisartan—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000164	0.00399	CcSEcCtD
Telmisartan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00397	CcSEcCtD
Telmisartan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000161	0.00391	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000154	0.00374	CcSEcCtD
Telmisartan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00371	CcSEcCtD
Telmisartan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.00368	CcSEcCtD
Telmisartan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00366	CcSEcCtD
Telmisartan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00365	CcSEcCtD
Telmisartan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00361	CcSEcCtD
Telmisartan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00357	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00354	CcSEcCtD
Telmisartan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00354	CcSEcCtD
Telmisartan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.00351	CcSEcCtD
Telmisartan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.00351	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.000139	0.0157	CbGpPWpGaD
Telmisartan—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00338	CcSEcCtD
Telmisartan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00336	CcSEcCtD
Telmisartan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00326	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000134	0.015	CbGpPWpGaD
Telmisartan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.00324	CcSEcCtD
Telmisartan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000133	0.00324	CcSEcCtD
Telmisartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000131	0.0148	CbGpPWpGaD
Telmisartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000126	0.0142	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000124	0.014	CbGpPWpGaD
Telmisartan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000124	0.00302	CcSEcCtD
Telmisartan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000121	0.00294	CcSEcCtD
Telmisartan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.0029	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	0.000118	0.0133	CbGpPWpGaD
Telmisartan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000115	0.00281	CcSEcCtD
Telmisartan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000111	0.00271	CcSEcCtD
Telmisartan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000107	0.00261	CcSEcCtD
Telmisartan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00259	CcSEcCtD
Telmisartan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00258	CcSEcCtD
Telmisartan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.00257	CcSEcCtD
Telmisartan—PPARG—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.000101	0.0114	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000101	0.0113	CbGpPWpGaD
Telmisartan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0001	0.00244	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	9.85e-05	0.0111	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	9.75e-05	0.011	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	9.57e-05	0.0108	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	9.28e-05	0.0105	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	9.18e-05	0.0103	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	8.72e-05	0.00982	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	8.56e-05	0.00964	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	8.44e-05	0.00951	CbGpPWpGaD
Telmisartan—Losartan—ALB—focal segmental glomerulosclerosis	8.43e-05	0.0248	CrCbGaD
Telmisartan—AGTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	8.15e-05	0.00918	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MYH10—focal segmental glomerulosclerosis	7.9e-05	0.0089	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	7.89e-05	0.00889	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	7.49e-05	0.00844	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	7.29e-05	0.00821	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	6.79e-05	0.00765	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	6.42e-05	0.00723	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	6.32e-05	0.00712	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	6.24e-05	0.00703	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—LPL—focal segmental glomerulosclerosis	6.1e-05	0.00688	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	5.98e-05	0.00674	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	5.97e-05	0.00673	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	5.84e-05	0.00658	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	5.84e-05	0.00658	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	5.73e-05	0.00645	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	5.65e-05	0.00637	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	5.37e-05	0.00605	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	5.24e-05	0.00591	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—AGT—focal segmental glomerulosclerosis	5.22e-05	0.00588	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	5.18e-05	0.00583	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	5.07e-05	0.00571	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	5.03e-05	0.00567	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	4.93e-05	0.00555	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	4.89e-05	0.00551	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	4.69e-05	0.00528	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	4.54e-05	0.00511	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	4.36e-05	0.00491	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MYH9—focal segmental glomerulosclerosis	4.33e-05	0.00488	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	4.27e-05	0.00481	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	4.18e-05	0.00471	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	4.02e-05	0.00454	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	4.01e-05	0.00452	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	3.85e-05	0.00434	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	3.65e-05	0.00411	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.6e-05	0.00405	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	3.47e-05	0.00391	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	3.36e-05	0.00379	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	3.34e-05	0.00376	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.32e-05	0.00374	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	3.25e-05	0.00366	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	3.23e-05	0.00364	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	3.22e-05	0.00362	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	3.19e-05	0.00359	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.17e-05	0.00357	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.07e-05	0.00346	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	2.83e-05	0.00319	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	2.78e-05	0.00313	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	2.76e-05	0.00311	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	2.72e-05	0.00307	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.7e-05	0.00305	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.7e-05	0.00304	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	2.64e-05	0.00298	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.61e-05	0.00294	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	2.53e-05	0.00286	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	2.52e-05	0.00284	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	2.51e-05	0.00283	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.4e-05	0.0027	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.37e-05	0.00268	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	2.32e-05	0.00262	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.2e-05	0.00247	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	2.11e-05	0.00238	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—LPL—focal segmental glomerulosclerosis	2.1e-05	0.00236	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.07e-05	0.00233	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.03e-05	0.00228	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.94e-05	0.00218	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.88e-05	0.00212	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.87e-05	0.00211	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	1.8e-05	0.00203	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.64e-05	0.00185	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	1.63e-05	0.00184	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.6e-05	0.00181	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.6e-05	0.00181	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	1.55e-05	0.00174	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	1.49e-05	0.00168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.49e-05	0.00168	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.49e-05	0.00168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.48e-05	0.00167	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.47e-05	0.00165	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.44e-05	0.00162	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.41e-05	0.00159	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.41e-05	0.00158	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.37e-05	0.00154	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—LIPC—focal segmental glomerulosclerosis	1.37e-05	0.00154	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.36e-05	0.00153	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.3e-05	0.00146	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.25e-05	0.0014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.24e-05	0.0014	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.23e-05	0.00139	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CTGF—focal segmental glomerulosclerosis	1.2e-05	0.00136	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.12e-05	0.00126	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.11e-05	0.00125	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.09e-05	0.00123	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.06e-05	0.00119	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	9.97e-06	0.00112	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.81e-06	0.0011	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—LPL—focal segmental glomerulosclerosis	9.78e-06	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.66e-06	0.00109	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.37e-06	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.88e-06	0.001	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	8.78e-06	0.000989	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	8.71e-06	0.000982	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.53e-06	0.000961	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGT—focal segmental glomerulosclerosis	8.37e-06	0.000943	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—LPL—focal segmental glomerulosclerosis	8.34e-06	0.00094	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.09e-06	0.000911	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.02e-06	0.000903	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.57e-06	0.000853	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.41e-06	0.000835	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.34e-06	0.000828	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGT—focal segmental glomerulosclerosis	7.14e-06	0.000804	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	7.06e-06	0.000795	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.47e-06	0.000729	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—focal segmental glomerulosclerosis	6.42e-06	0.000723	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.16e-06	0.000695	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	6.08e-06	0.000686	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	5.52e-06	0.000622	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—focal segmental glomerulosclerosis	5.48e-06	0.000617	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.39e-06	0.000607	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	5.2e-06	0.000586	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.97e-06	0.00056	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	4.86e-06	0.000548	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.75e-06	0.000535	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.72e-06	0.000532	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.61e-06	0.000519	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.48e-06	0.000505	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.37e-06	0.000493	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	3.99e-06	0.00045	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.89e-06	0.000438	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	3.37e-06	0.00038	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	3.29e-06	0.000371	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.88e-06	0.000325	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.81e-06	0.000317	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	2.21e-06	0.000249	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.16e-06	0.000243	CbGpPWpGaD
